Lista de obras -

A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells ⬇️

artículo científico publicado el 22 de noviembre de 2010

Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.

artículo científico publicado en 2005

An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.

artículo científico publicado en 2004

Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.

artículo científico publicado en 2003

Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation

artículo científico publicado en 2010

Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice

artículo científico publicado en 2006

Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense

artículo científico publicado en 2006

Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense ⬇️

artículo científico publicado en 2021

Differential Roles of PML Isoforms

artículo científico publicado en 2013

Differential effects of SUMO1 and SUMO3 on PKR activation and stability.

artículo científico publicado en 2018

Implication of PML nuclear bodies in intrinsic and innate immunity

artículo científico publicado en 2014

Implication of PMLIV in both intrinsic and innate immunity

artículo científico publicado en 2014

Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities

artículo científico publicado en 2008

Interferon, a growing cytokine family: 50 years of interferon research

artículo científico publicado en 2007

Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively

artículo científico publicado en 2005

Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling.

artículo científico publicado en 2014

MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.

artículo científico publicado en 2016

MxA interacts with and is modified by the SUMOylation machinery.

artículo científico publicado en 2014

Negative regulation of the JAK/STAT: pathway implication in tumorigenesis

artículo científico publicado en 2005

Novel function of STAT1beta in B cells: induction of cell death by a mechanism different from that of STAT1alpha.

artículo científico publicado en 2008

PML and PML nuclear bodies: implications in antiviral defence

artículo científico publicado en 2007

PML control of cytokine signaling.

artículo científico

PML positively regulates interferon gamma signaling

artículo científico publicado en 2010

PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx

artículo científico publicado en 2015

Promyelocytic Leukemia Isoform IV Confers Resistance to Encephalomyocarditis Virus via the Sequestration of 3D Polymerase in Nuclear Bodies ⬇️

artículo científico publicado el 12 de octubre de 2011

Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation

scientific article published on 13 March 2018

Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies

artículo científico publicado en 2006

Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies.

artículo científico publicado en 2002

Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways

artículo científico publicado en 2005

Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms

artículo científico publicado en 2012

Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses

artículo científico publicado en 2015

Resistance to rabies virus infection conferred by the PMLIV isoform

artículo científico publicado en 2010

Rhabdoviruses, Antiviral Defense, and SUMO Pathway

scholarly article by Faten El Asmi et al published 3 December 2018 in Viruses

Role of Promyelocytic Leukemia Protein in Host Antiviral Defense ⬇️

artículo científico publicado el 3 de enero de 2011

Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.

artículo científico publicado en 2009

SUMOylation promotes PML degradation during encephalomyocarditis virus infection.

artículo científico publicado en 2010

Small Ubiquitin-like Modifier Alters IFN Response

artículo científico publicado en 2015

Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells

artículo científico publicado en 2014

The exonuclease ISG20 mainly localizes in the nucleolus and the Cajal (Coiled) bodies and is associated with nuclear SMN protein-containing complexes

artículo científico publicado en 2006

The implication of SUMO in intrinsic and innate immunity

artículo científico publicado en 2016

The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1.

artículo científico publicado en 2007

Transcriptional profiling reveals a possible role for the timing of the inflammatory response in determining susceptibility to a viral infection

artículo científico publicado en 2006

Uncovering the SUMOylation and ubiquitylation crosstalk in human cells using sequential peptide immunopurification

artículo científico publicado en 2017

[New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases]

scientific article published on 01 November 2008

[SUMO paralogs and interferon response].

artículo científico publicado en 2016

Lista de obras de

A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells ⬇️

Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.

An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.

Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.

Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation

Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice

Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense

Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense ⬇️

Differential Roles of PML Isoforms

Differential effects of SUMO1 and SUMO3 on PKR activation and stability.

Implication of PML nuclear bodies in intrinsic and innate immunity

Implication of PMLIV in both intrinsic and innate immunity

Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities

Interferon, a growing cytokine family: 50 years of interferon research

Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively

Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling.

MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.

MxA interacts with and is modified by the SUMOylation machinery.

Negative regulation of the JAK/STAT: pathway implication in tumorigenesis

Novel function of STAT1beta in B cells: induction of cell death by a mechanism different from that of STAT1alpha.

PML and PML nuclear bodies: implications in antiviral defence

PML control of cytokine signaling.

PML positively regulates interferon gamma signaling

PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx

Promyelocytic Leukemia Isoform IV Confers Resistance to Encephalomyocarditis Virus via the Sequestration of 3D Polymerase in Nuclear Bodies ⬇️

Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation

Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies

Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies.

Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways

Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms

Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses

Resistance to rabies virus infection conferred by the PMLIV isoform

Rhabdoviruses, Antiviral Defense, and SUMO Pathway

Role of Promyelocytic Leukemia Protein in Host Antiviral Defense ⬇️

Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.

SUMOylation promotes PML degradation during encephalomyocarditis virus infection.

Small Ubiquitin-like Modifier Alters IFN Response

Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells

The exonuclease ISG20 mainly localizes in the nucleolus and the Cajal (Coiled) bodies and is associated with nuclear SMN protein-containing complexes

The implication of SUMO in intrinsic and innate immunity

The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1.

Transcriptional profiling reveals a possible role for the timing of the inflammatory response in determining susceptibility to a viral infection

Uncovering the SUMOylation and ubiquitylation crosstalk in human cells using sequential peptide immunopurification

[New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases]

[SUMO paralogs and interferon response].